Financials • Life Insurance
$21.05 ▲ +0.45
(+2.18%)
MKT CAP: $2.76B • VOL: 497.5K
52W L $19 52W H $35
ROARABLE / RQD
D+ • 55/100
PIOTROSKI
4 / 9
FG // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $5.73B | $5.74B | $4.50B |
| YoY Revenue Growth % | -0.2% | +27.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $248.0M | $642.0M | -$58.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $4.68B | $6.00B | $5.83B |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $4.68B | $6.00B | $5.83B |
| FCF Margin % | 80.0% | 80.0% | 80.0% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $1.49B | $2.26B | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.80B | $3.95B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR FG.